Lupus Cognitive Impairment SLE | Medical Algorithm

Are you evaluating a patient with SLE?

Yes

Does/Is the patient?

• have hypertension?

Yes

• obese?

Yes

• have the antiphospholipid antibody syndrome?

Yes

• have moderate or severe changes in the cerebral MRI?

Yes

• have Raynaud's phenomenon?

Yes

• have accumulated damage with SLICC/ACR Damage Index >= 1?

Yes

Results

Please fill out required fields.

Results Interpretation and Description References Next Steps

Data complete?

Evaluation appropriate?

Number of risk factors for cognitive impairment

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Seamlessly integrate our API library of over 5,000 evidence-based medical analytics into your products and workflows. Our APIs help you:

Build custom, automated clinical workflows tailored to your organization's needs.
Enhance your clinical decision support with advanced, evidence-based analytics.
Streamline revenue cycle management by integrating clinical analytics into billing, coding, and compliance processes.
Support payment and pre-approval processes with automated, standardized medical criteria.
Embed proven medical algorithms directly into your systems and services for consistent, high-quality outcomes.

With MedicalAlgorithms.com APIs, you can accelerate innovation, improve efficiency, and deliver more accurate, data-driven care—without reinventing the wheel.

Explore Medal API

Caution: A qualified health practitioner should verify all results.
Keep patient data confidential and comply with all legal requirements.

Please visit our website Medicalalgorithms.com for Description and Interpretation and further algorithms you may want to consider in the next steps of your evaluation. All information should be verified by a qualified health professional, and all use is subject to Medicalalgorithms.com Terms and Conditions. © Copyright Medicalalgorithms.com Limited

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Risk Factors
Clinical Diagnosis, Including Family History For Genetics
Imaging Studies
Laboratory Tests
Other Testing
- Clinical Features of Acute Lupus Pneumonitis
Criteria For Diagnosis
Severity, Prognosis, Stage
Complications
- Systemic Lupus Erythematosus (SLE) | Moyamoya Syndrome
Differential Diagnosis And Mimics, Red Flags

Therapy

Pharmacogenetics
Drug Interactions
- SELENA Flare Tool
- Diagnostic Features of Drug-Induced Lupus Erythematosus (DIL)
Prevention
Interventional Radiology
- Severity of CNS Changes on Cranial MRI | Systemic Lupus Erythematosus
- Neuropsychiatric Syndromes in Systemic Lupus Erythematosus (SLE)

Monitoring

Drug Levels
- SELENA Flare Tool
- Diagnostic Features of Drug-Induced Lupus Erythematosus (DIL)
Disease Progression
Complication Detection
Comorbid Conditions

Patient Concerns

Quality Of Life
- Total Activity Score of Cutaneous LE Disease Area and Severity Index (CLASI)
- Neuropsychiatric Syndromes in Systemic Lupus Erythematosus (SLE)
Psychological Response

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Patient Concerns

Specialty

Objective

ICD-10

Risk Factors for Cognitive Impairment in SLE

Purpose: To identify factors that may affect the severity of cognitive impairment in a patient with SLE as reported by Tomietto et al.

Evaluation

Results

Please fill out required fields.

MedicalAlgorithms.com APIs

Power Your Solutions with 5,000+ Automated Medical Analytics

Interpretation and Description

References

Next Steps in Evaluation

Diagnosis

Therapy

Monitoring

Patient Concerns

Specialty

Objective

ICD-10